D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
$601M |
| 2 |
Walt Disney
DIS
|
$510M |
| 3 |
Palantir
PLTR
|
$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$490M |
| 5 |
TSMC
TSM
|
$396M |
Top Sells
| 1 |
Boeing
BA
|
$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$567M |
| 4 |
Eli Lilly
LLY
|
$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
New York Times
NYT
$9.6B
| $40.2M | 0.04% |
810,997
+214,476
| +36% | +$10.6M |
|
352
Logitech
LOGI
$15.8B
| $40.2M | 0.04% |
476,442
+117,569
| +33% | +$9.92M |
|
353
Williams Companies
WMB
$69.9B
| $39.8M | 0.04% |
666,370
+446,811
| +204% | +$26.7M |
|
354
Mattel
MAT
$6.06B
| $39.7M | 0.04% |
2,043,906
+1,091,646
| +115% | +$21.2M |
|
355
Halozyme
HALO
$8.76B
| $39.5M | 0.04% |
619,562
-211,852
| -25% | -$13.5M |
|
356
Goosehead Insurance
GSHD
$2.11B
| $39.4M | 0.04% |
333,781
+129,812
| +64% | +$15.3M |
|
357
Sempra
SRE
$52.9B
| $39.3M | 0.04% |
+550,474
| New | +$39.3M |
|
358
First Majestic Silver
AG
$4.47B
| $39.3M | 0.03% |
5,869,144
-3,405,128
| -37% | -$22.8M |
|
359
Bunge Global
BG
$16.9B
| $39.2M | 0.03% |
513,480
-448,428
| -47% | -$34.3M |
|
360
NOV
NOV
$4.95B
| $39.2M | 0.03% |
2,577,229
+505,469
| +24% | +$7.69M |
|
361
ASML
ASML
$307B
| $39.1M | 0.03% |
58,955
-170,648
| -74% | -$113M |
|
362
Acadia Pharmaceuticals
ACAD
$4.26B
| $39M | 0.03% |
2,349,420
-891,986
| -28% | -$14.8M |
|
|
VRNA
363
Verona Pharma
VRNA
$9.2B
| $39M | 0.03% |
+613,997
| New | +$39M |
|
364
Corebridge Financial
CRBG
$18.1B
| $38.6M | 0.03% |
1,224,120
+67,008
| +6% | +$2.12M |
|
365
Starwood Property Trust
STWD
$7.56B
| $38.6M | 0.03% |
+1,953,010
| New | +$38.6M |
|
366
BioMarin Pharmaceuticals
BMRN
$11.1B
| $38.6M | 0.03% |
545,775
+270,323
| +98% | +$19.1M |
|
367
Toro Company
TTC
$7.99B
| $38.5M | 0.03% |
528,627
+188,822
| +56% | +$13.7M |
|
|
ONC
368
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $38.3M | 0.03% |
+140,574
| New | +$38.3M |
|
369
Eaton
ETN
$136B
| $38.2M | 0.03% |
140,387
+93,558
| +200% | +$25.4M |
|
370
Option Care Health
OPCH
$4.72B
| $37.9M | 0.03% |
1,085,101
+884,350
| +441% | +$30.9M |
|
371
Estee Lauder
EL
$32.1B
| $37.8M | 0.03% |
572,726
-1,863,162
| -76% | -$123M |
|
372
IAMGOLD
IAG
$5.7B
| $37.6M | 0.03% |
6,020,969
+734,923
| +14% | +$4.59M |
|
373
Altria Group
MO
$112B
| $37.6M | 0.03% |
625,823
+66,728
| +12% | +$4.01M |
|
374
Lincoln Electric
LECO
$13.5B
| $37.3M | 0.03% |
197,089
+174,593
| +776% | +$33M |
|
375
Valmont Industries
VMI
$7.46B
| $37.2M | 0.03% |
130,511
-2,081
| -2% | -$594K |
|